To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

255.152 days ago
260.802 days ago
arrow

LOWER/UPPER CIRCUITS

207.15
310.65
arrow
Marksans Pharma Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 43.52%
Net profit growth 5Y CAGR : 31.38%
Marksans Pharma Limited Top mutual funds holding
arrow
Marksans Pharma is an Indian pharmaceutical company having a global footprint. Their strengths lie in research manufacturing and marketing of finished dosage pharmaceutical formulations. The company’s R&D capabilities include dossier development chemical synthesis process optimization formulation development analytical development and conducting stability studies. Its key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology Gastroenterology Antidiabetic Antibiotics Cardiovascular Pain Management Gynaecology among others. The company manufacture a wide range of solid oral dosage in the form of Tablets (plain enteric coated and film coated) Hard Gelatin Capsule and Soft Gelatin Capsules.
personal

Grow your wealth with more research recommendations

+91